Dodecanoylcarnitine
|
Basic information |
| Metabolite name | Dodecanoylcarnitine |
 | HMDB0002250 |
 |
N/A |
 |
168381 |
| Synonyms | Dodecanoyl-L-carnitine; |
| No. of studies | 8 |
|
Basic information |
| Metabolite name | Dodecanoylcarnitine |
| HMDB0002250 |
|
N/A |
|
168381 |
| Synonyms | Dodecanoyl-L-carnitine; |
| No. of studies | 8 |
|
Relationship between Dodecanoylcarnitine and depression (count: 8) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Down |
| Study M1021 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M1021 | Type2 | depression group, after 6-month antidepressant treatment vs. baseline | Plasma | Human | Up |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M587 | Type2 | MDD group, after 8-week SSRI treatment vs. before treatment | Plasma | Human | Down |
| Study M741 | Type2 | MDD group, post vs. before SSRI treatment | Plasma | Human | Down |
| Study M773 | Type1 | antenatal depression group vs. non-antenatal depression group | Serum | Human | Up |
| Study M801 | Type1 | depression group vs. control group | Plasma | Human | Down |
| Study M801 | Type1 | depression group vs. control group | Serum | Human | Down |
| Study M870 | Type1 | CRS group vs. control group | Brain | C57BL/6 mouse | Up |
| Study M870 | Type2 | CRS + sertraline group vs. CRS group | Brain | C57BL/6 mouse | Down |
| Study M870 | Type2 | CRS + middle dose of Jia Wei Xiao Yao San group vs. CRS group | Brain | C57BL/6 mouse | Down |